Literature DB >> 20379783

Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience.

Anna Fagotti1, Barbara Costantini, Francesco Fanfani, Giuseppe Vizzielli, Cristiano Rossitto, Antonella Lecca, Giovanni Scambia.   

Abstract

PURPOSE: This study was undertaken to evaluate risk factors for the occurrence of postoperative abscesses in a large single-institution series of gynecologic cancer patients undergoing major surgery.
MATERIALS AND METHODS: Patients admitted to the Division of Gynecologic Oncology, Catholic University of Sacred Hearth, Rome, Italy, between January 2008 and February 2009, were retrospectively analyzed. The occurrence of pelvic abscesses was identified by sign and symptoms and confirmed with radiological and microbiological examinations.
RESULTS: A total of 360 patients were analyzed for the study. Exenteration and use of fibrillar absorbable hemostat were significantly associated with the presence of postoperative abscesses (P < .0001) by multiple regression analysis, whereas operative time, type of surgery, lymphadenectomy, or other associated surgical procedures failed to result statistically relevant.
CONCLUSIONS: The use of fibrillar oxidized regenerated cellulose as hemostatic agent may represent a risk factor for postoperative abscesses, especially when used during pelvic exenteration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379783     DOI: 10.1245/s10434-010-1059-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan.

Authors:  John A Harris; Anne G Sammarco; Carolyn W Swenson; Shitanshu Uppal; Neil Kamdar; Darrel Campbell; Sarah Evilsizer; John O DeLancey; Daniel M Morgan
Journal:  Am J Obstet Gynecol       Date:  2017-01-09       Impact factor: 8.661

2.  Innovative non-surgical management of pelvic and anterior vaginal wall abscess following vaginal surgery.

Authors:  Nisha Singh; Neha Negi; Namrata Kumar
Journal:  BMJ Case Rep       Date:  2016-08-29

3.  A retrospective cohort study of hemostatic agent use during hysterectomy and risk of post-operative complications.

Authors:  John A Harris; Shitanshu Uppal; Neil Kamdar; Carolyn W Swenson; Darrell Campbell; Daniel M Morgan
Journal:  Int J Gynaecol Obstet       Date:  2016-11-16       Impact factor: 3.561

Review 4.  Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents.

Authors:  Devin T Miller; Dana M Roque; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2015-01-08       Impact factor: 8.661

Review 5.  Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials.

Authors:  Maria Luisa Gasparri; Thorsten Kuehn; Ilary Ruscito; Veronica Zuber; Rosa Di Micco; Ilaria Galiano; Siobana C Navarro Quinones; Letizia Santurro; Francesca Di Vittorio; Francesco Meani; Valerio Bassi; Nina Ditsch; Michael D Mueller; Filippo Bellati; Donatella Caserta; Andrea Papadia; Oreste D Gentilini
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

Review 6.  Infection Prevention and Evaluation of Fever After Laparoscopic Hysterectomy.

Authors:  Mark P Lachiewicz; Laura J Moulton; Oluwatosin Jaiyeoba
Journal:  JSLS       Date:  2015 Jul-Sep       Impact factor: 2.172

Review 7.  Pelvic surgical site infections in gynecologic surgery.

Authors:  Mark P Lachiewicz; Laura J Moulton; Oluwatosin Jaiyeoba
Journal:  Infect Dis Obstet Gynecol       Date:  2015-02-18

8.  Systematic Review of Topical Hemostatic Agent Use in Minimally Invasive Gynecologic Surgery.

Authors:  Traci E Ito; Alexandra L Martin; Edith F Henderson; Jeremy T Gaskins; Vida M Vaughn; Shan M Biscette; Resad P Pasic
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

9.  Exploring Adverse Events and Utilization of Topical Hemostatic Agents in Surgery.

Authors:  Katherine A O'Hanlan; Paul Bassett
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.